Home Medicine Investigating the kynurenine pathway in pediatric metabolic health
Article
Licensed
Unlicensed Requires Authentication

Investigating the kynurenine pathway in pediatric metabolic health

  • Fatma Özgüç Çömlek ORCID logo EMAIL logo , Dilek Bingöl Aydın ORCID logo , Fikret Akyürek , Muslu Kazım Körez and Fuat Buğrul
Published/Copyright: October 30, 2025

Abstract

Objectives

The rise in obesity has led to a higher incidence of metabolic diseases in children. Overnutrition leads to increased intake and availability of tryptophan (TRP). Research indicates a link between indoleamine 2,3-dioxygenase (IDO) activity, the activation of the tryptophan catabolic pathway, and inflammation associated with obesity. This study investigated how pediatric obesity affects tryptophan metabolism and its potential link to metabolic syndrome.

Methods

This prospective cohort study included 86 children aged 10 years and older, 56 of whom were obese. Obese children with body mass index (BMI) >95th percentile were divided into two groups: obese (BMI greater than 120 % of the 95th percentile for age and sex) and severely obese (BMI greater than 140 % of the 95th percentile for age and sex). Serum levels of kynurenine pathway metabolites were determined by liquid chromatography-mass spectrometry/mass spectrometry system.

Results

The mean ages (13.6 and 13.2 years) and gender distribution (36.7 and 46.2 % male) were similar across the groups. There were significant differences in tryptophan levels between the groups, being higher in the obese groups (p<0.001). 3-hydroxykynurenine (3HK) was significantly higher in the obese group (p=0.029). 3-hydroxykynurenine/kynurenine (3HK/KYN) ratio also significantly correlated with increased GGT and triglyceride levels and low HDL. Also higher 3HK/KYN ratio was correlated with elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels. No significant relationship was found between the KYN/TRP ratio and obesity metabolic syndrome indicators.

Conclusions

Although plasma kynurenine pathway metabolites showed some changes in children with obesity, larger series studies are needed to determine the relationship with metabolic syndrome.


Corresponding author: Dr. Fatma Özgüç Çömlek, Selçuk Üniversity Medical Faculty, Pediatric Endocrinology, Konya, Türkiye, E-mail:

  1. Research ethics: Approval for the study was obtained from the Selçuk University Faculty of Medicine ethics committee with the decision number 2025/287.

  2. Informed consent: Informed consent was obtained from the patients and their parents who participated in the study.

  3. Author contributions: Concept- Fatma Özgüç Çömlek, Design- Fatma Özgüç Çömlek Supervision- Fatma Özgüç Çömlek, Dilek Bingöl Aydın Materials, Fatma Özgüç Çömlek, data Collection and /or Processing- Fatma Özgüç Çömlek, Fuat Buğrul, Fikret Akyürek Analysis and /or interpretation- Fatma Özgüç Çömlek,Fikret Akyürek, Muslu Kazım Körez Literature Review Fatma Özgüç Çömlek, Dilek Bingöl Aydın, Fuat Buğrul Writer- Fatma Özgüç Çömlek, Muslu Kazım Körez;Critical Review- Fatma Özgüç Çömlek, Muslu Kazım Körez.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Data can be shared upon request.

References

1. Weihrauch-Blüher, S, Schwarz, P, Klusmann, JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism 2019;92:147–52. https://doi.org/10.1016/j.metabol.2018.12.001.Search in Google Scholar PubMed

2. Caprio, S, Santoro, N, Weiss, R. Childhood obesity and the associated rise in cardiometabolic complications. Nat Metab 2020;2:223–32. https://doi.org/10.1038/s42255-020-0183-z.Search in Google Scholar PubMed PubMed Central

3. Nadeau, KJ, Maahs, DM, Daniels, SR, Eckel, RH. Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol 2011;8:513–25. https://doi.org/10.1038/nrcardio.2011.86.Search in Google Scholar PubMed PubMed Central

4. Vukovic, R, Dos Santos, TJ, Ybarra, M, Atar, M. Children with metabolically healthy obesity: a review. Front Endocrinol 2019;10:865. https://doi.org/10.3389/fendo.2019.00865.Search in Google Scholar PubMed PubMed Central

5. Damanhoury, S, Newton, AS, Rashid, M, Hartling, L, Byrne, JLS, Ball, GDC. Defining metabolically healthy obesity in children: a scoping review. Obes Rev 2018;19:1476–91. https://doi.org/10.1111/obr.12721.Search in Google Scholar PubMed

6. Blüher, M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009;117:241–50. https://doi.org/10.1055/s-0029-1192044.Search in Google Scholar PubMed

7. Maury, E, Brichard, S. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1–16. https://doi.org/10.1016/j.mce.2009.07.031.Search in Google Scholar PubMed

8. de Heredia, FP, Gómez-Martínez, S, Marcos, A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012;71:332–8. https://doi.org/10.1017/s0029665112000092.Search in Google Scholar

9. Bernard, A, Le May, C, Dastugue, A, Ayer, A, Blanchard, C, Martin, JC, et al.. The tryptophan/kynurenine pathway: a novel cross-talk between nutritional obesity, bariatric surgery and taste of fat. Nutrients 2021;13:1366. https://doi.org/10.3390/nu13041366.Search in Google Scholar PubMed PubMed Central

10. Liu, JJ, Movassat, J, Portha, B. Emerging role for kynurenines in metabolic pathologies. Curr Opin Clin Nutr Metab Care 2019;22:82–90. https://doi.org/10.1097/mco.0000000000000529.Search in Google Scholar PubMed

11. Brandacher, G, Hoeller, E, Fuchs, D, Weiss, H. Chronic immune activation underlies morbid obesity: is IDO A key player? Curr Drug Metabol 2007;8:289–95. https://doi.org/10.2174/138920007780362590.Search in Google Scholar PubMed

12. Strasser, B, Berger, K, Fuchs, D. Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur J Nutr 2014;54:101–7. https://doi.org/10.1007/s00394-014-0690-3.Search in Google Scholar PubMed

13. Badawy, AA, Guillemin, G. The plasma [Kynurenine]/[Tryptophan] ratio and indoleamine 2,3-Dioxygenase: time for appraisal. Int J Tryptophan Res 2019;12, 1178646919868978. https://doi.org/10.1177/1178646919868978.Search in Google Scholar PubMed PubMed Central

14. Miura, H, Ozaki, N, Sawada, M, Isobe, K, Ohta, T, Nagatsu, T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 2008;11:198–209. https://doi.org/10.1080/10253890701754068.Search in Google Scholar PubMed

15. Chaves Filho, AJM, Lima, CNC, Vasconcelos, SMM, de Lucena, DF, Maes, M, Macedo, D. IDO chronic immune activation and tryptophan metabolic pathway: a potential pathophysiological link between depression and obesity. Prog Neuropsychopharmacol Biol Psychiatry 2018;80:234–49. https://doi.org/10.1016/j.pnpbp.2017.04.035.Search in Google Scholar PubMed

16. Mangge, H, Summers, KL, Meinitzer, A, Zelzer, S, Almer, G, Prassl, R, et al.. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity (Silver Spring) 2014;22:195–201. https://doi.org/10.1002/oby.20491.Search in Google Scholar PubMed

17. Favennec, M, Hennart, B, Caiazzo, R, Leloire, A, Yengo, L, Verbanck, M, et al.. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity (Silver Spring) 2015;23:2066–74. https://doi.org/10.1002/oby.21199.Search in Google Scholar PubMed

18. Yu, E, Papandreou, C, Ruiz-Canela, M, Guasch-Ferre, M, Clish, CB, Dennis, C, et al.. Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial: a case-cohort study. Clin Chem 2018;64:1211–20. https://doi.org/10.1373/clinchem.2018.288720.Search in Google Scholar PubMed PubMed Central

19. Rebnord, EW, Strand, E, Midttun, Ø, Svingen, GFT, Christensen, MHE, Ueland, PM, et al.. The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia 2017;60:1712–21. https://doi.org/10.1007/s00125-017-4329-9.Search in Google Scholar PubMed PubMed Central

20. Rojas, IY, Moyer, BJ, Ringelberg, CS, Wilkins, OM, Pooler, DB, Ness, DB, et al.. Kynurenine-induced aryl hydrocarbon receptor signaling in mice causes body mass gain, liver steatosis, and hyperglycemia. Obesity 2021;29:337–49. https://doi.org/10.1002/oby.23065.Search in Google Scholar PubMed PubMed Central

21. Deac, OM, Mills, JL, Shane, B, Midttun, Ø, Ueland, PM, Brosnan, JT, et al.. Tryptophan catabolism and vitamin B-6 status are affected by gender and lifestyle factors in healthy young adults. J Nutr 2015;145:701–7. https://doi.org/10.3945/jn.114.203091.Search in Google Scholar PubMed PubMed Central

22. Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303. https://doi.org/10.1136/adc.44.235.291.Search in Google Scholar PubMed PubMed Central

23. Öztürk, A, Borlu, A, Çiçek, B 0–18 yaş çocuk ve adolesanlarda büyüme eğrileri. Türk Aile Hek Der 2011;15:112–9.10.2399/tahd.11.112Search in Google Scholar

24. Skinner, AC, Ravanbakht, SN, Skelton, JA, Perrin, EM, Armstrong, SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics 2018;141:e20173459. https://doi.org/10.1542/peds.2017-3459.Search in Google Scholar PubMed PubMed Central

25. Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC. Homeostasis model assessment: In-Sulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19. https://doi.org/10.1007/bf00280883.Search in Google Scholar PubMed

26. Zimmet, P, Alberti, KG, Kaufman, F, Tajima, N, Silink, M, Arslanian, S, et al.. The metabolic syndrome in children and adolescents–an IDF consensus report. Pediatr Diabetes 2007;8:299–306. https://doi.org/10.1111/j.1399-5448.2007.00271.x.Search in Google Scholar PubMed

27. Tong, Q, Song, J, Yang, G, Fan, L, Xiong, W, Fang, J. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring. Biomed Chromatogr 2018;32:e4156. https://doi.org/10.1002/bmc.4156.Search in Google Scholar PubMed

28. Lischka, J, Schanzer, A, Baumgartner, M, de Gier, C, Greber-Platzer, S, Zeyda, M. Tryptophan metabolism is associated with BMI and adipose tissue mass and linked to metabolic disease in pediatric obesity. Nutrients 2022;14:286. https://doi.org/10.3390/nu14020286.Search in Google Scholar PubMed PubMed Central

29. Tan, KM, Tint, MT, Kothandaraman, N, Yap, F, Godfrey, KM, Lee, YS, et al.. Association of plasma kynurenine pathway metabolite concentrations with metabolic health risk in prepubertal Asian children. Int J Obes 2022;46:1128–37. https://doi.org/10.1038/s41366-022-01085-4.Search in Google Scholar PubMed PubMed Central

30. Kubacka, J, Staniszewska, M, Sadok, I, Sypniewska, G, Stefanska, A. The kynurenine pathway in Obese middle-aged women with normoglycemia and type 2 diabetes. Metabolites 2022;12:492. https://doi.org/10.3390/metabo12060492.Search in Google Scholar PubMed PubMed Central

31. Valente-Silva, P, Cervenka, I, Ferreira, DMS, Correia, JC, Edman, S, Horwath, O, et al.. Effects of tryptophan supplementation and exercise on the fate of kynurenine metabolites in mice and humans. Metabolites 2021;11. https://doi.org/10.3390/metabo11080508.Search in Google Scholar PubMed PubMed Central

Received: 2025-08-20
Accepted: 2025-10-11
Published Online: 2025-10-30
Published in Print: 2025-12-17

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Subclinical but significant? Updated review of pediatric hypothyroidism
  4. Original Articles
  5. The differential impact of automated insulin delivery systems on body mass index in children with type 1 diabetes
  6. Maturity-onset diabetes of the young due to HNF1β variants (HNF1β-MODY): a 2-year follow-up study of six patients from a single diabetes center
  7. Investigating the kynurenine pathway in pediatric metabolic health
  8. Mucolipidosis type II and III: clinical spectrum, genetic landscape, and longitudinal outcomes in a pediatric cohort with six novel mutations
  9. Evaluation of the genetic alterations landscape of differentiated thyroid cancer in children
  10. Prognostic analysis of persistent disease in medium-to high-risk children and adolescents with differentiated thyroid carcinoma
  11. The clinical picture of symptomatic Rathke cleft cysts in children
  12. Pitfalls in the diagnosis of carnitine palmitoyltransferase 1 deficiency
  13. Effective treatment of hyperphosphatemia with denosumab in patients with loss of function of FGF23 and high bone density: case series
  14. Case Reports
  15. Dual molecular genetic diagnosis with combined malonic and methylmalonic aciduria (CMAMMA): implications of coexisting genetic disorders on clinical presentation
  16. Family experience with individuals of different ages and clinical presentations diagnosed with DI: do familial DI cases tolerate polyuria better?
  17. Atypical pediatric presentation of hyperparathyroidism: CDC73 gene mutation and parathyroid carcinoma
  18. Pseudohypertriglyceridemia as a clue: clinical and genetic spectrum of glycerol kinase deficiency in three pediatric cases
  19. Transient worsening of thyrotoxic myopathy following methimazole and metoprolol initiation in a 12-year-old girl: a case report and literature review
  20. Letter to the Editor
  21. Cognitive behavioral therapy (CBT) effect on diabetic youth depression, death anxiety and glycemic control
  22. Annual Reviewer Acknowledgment
  23. Reviewer Acknowledgment
Downloaded on 9.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0477/html
Scroll to top button